Considerations To Know About semaglutide 5 mg vials
The trial reached both its Main endpoints, with semaglutide two.4 mg demonstrating statistically considerable and outstanding enhancements in liver fibrosis without any worsening of steatohepatitis, together with resolution of steatohepatitis with no worsening of liver fibrosis in people with MASH when compared to placebo.1These highlights tend not